Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tancini

Showing results (91-100 of 218) with videos related to

Pageof 22
Sort By:
Breast Cancer Research and Treatment|January 1, 1985
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerG Bonadonna, P Valagussa, A Rossi, et al.
British Medical Journal|December 6, 1975
Laparoscopy and laparotomy combined with bone marrow biopsy in staging Hodgkin's diseaseP Spinelli, G Beretta, E Bajetta, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: the Milan Institute experienceG Bonadonna, P Valagussa, A Rossi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Changes in T lymphocyte subsets after single dose epirubicinP Lissoni, G Tancini, C Archili, et al.
Tumori|February 28, 1990
Correlation of serum interleukin-2 levels, soluble interleukin-2 receptors and T lymphocyte subsets in cancer patientsP Lissoni, S Barni, F Rovelli, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 1, 1995
A randomized study of neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable metastatic solid tumourP Lissoni, S Barni, V Fossati, et al.
The International Journal of Biological Markers|October 1, 1992
Effect of interferon-alpha on soluble interleukin-2 receptor and tumor necrosis factor increase during immunotherapy with interleukin-2P Lissoni, A Ardizzoia, F Rovelli, et al.
British Journal of Cancer|April 1, 1995
Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen aloneP Lissoni, S Barni, S Meregalli, et al.
Oncology|July 1, 1994
Efficacy of the concomitant administration of the pineal hormone melatonin in cancer immunotherapy with low-dose IL-2 in patients with advanced solid tumors who had progressed on IL-2 aloneP Lissoni, S Barni, M Cazzaniga, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 1993
Respiratory distress syndrome in patients with advanced cancer treated with pentoxifylline: a randomized studyA Ardizzoia, P Lissoni, G Tancini, et al.
Pageof 22

Showing results (91-100 of 218) with videos related to

Sort By:
Pageof 22
Breast Cancer Research and Treatment|January 1, 1985
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerG Bonadonna, P Valagussa, A Rossi, et al.
British Medical Journal|December 6, 1975
Laparoscopy and laparotomy combined with bone marrow biopsy in staging Hodgkin's diseaseP Spinelli, G Beretta, E Bajetta, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: the Milan Institute experienceG Bonadonna, P Valagussa, A Rossi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Changes in T lymphocyte subsets after single dose epirubicinP Lissoni, G Tancini, C Archili, et al.
Tumori|February 28, 1990
Correlation of serum interleukin-2 levels, soluble interleukin-2 receptors and T lymphocyte subsets in cancer patientsP Lissoni, S Barni, F Rovelli, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 1, 1995
A randomized study of neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable metastatic solid tumourP Lissoni, S Barni, V Fossati, et al.
The International Journal of Biological Markers|October 1, 1992
Effect of interferon-alpha on soluble interleukin-2 receptor and tumor necrosis factor increase during immunotherapy with interleukin-2P Lissoni, A Ardizzoia, F Rovelli, et al.
British Journal of Cancer|April 1, 1995
Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen aloneP Lissoni, S Barni, S Meregalli, et al.
Oncology|July 1, 1994
Efficacy of the concomitant administration of the pineal hormone melatonin in cancer immunotherapy with low-dose IL-2 in patients with advanced solid tumors who had progressed on IL-2 aloneP Lissoni, S Barni, M Cazzaniga, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 1993
Respiratory distress syndrome in patients with advanced cancer treated with pentoxifylline: a randomized studyA Ardizzoia, P Lissoni, G Tancini, et al.
Pageof 22